Skip to content

Effects of transcutaneous electrical acupoint stimulation (TEAS) on postoperative acute and chronic pain in patients undergoing video-assisted thoracic surgical lobectomy

Effects of transcutaneous electrical acupoint stimulation (TEAS) on postoperative acute and chronic pain in patients undergoing video-assisted thoracic surgical lobectomy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069458
Enrollment
Unknown
Registered
2023-03-16
Start date
2023-03-20
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute and chronic postoperative pain

Interventions

Transcutaneous electrical acupoint stimulation (TEAS):PC6 (Neiguan point), LI4 (Hegu point), LR3 (Taichong point), LU5 (Chizze point), TE5 (Waiguan point) and LI11(Quchi point) were selected for bilat
Shan group (Control group):The same points were selected for false stimulation

Sponsors

People's Liberation Army Joint Logistic Support Force 920th Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years; 2. ASA grade I-III; 3. BMI 18.5-28; 4. Patients scheduled to undergo a VATS lobectomy; 5.Sign a written informed consent.

Exclusion criteria

Exclusion criteria: 1. Contraindications for TEAS (scarring or skin damage at the irritation site, electronic devices such as pacemakers or other implanted medical electronic devices in the body); 2. A history of chronic pain; 3. Previous medical conditions (diabetes mellitus, cerebral infarction, coronary heart disease, chronic kidney disease, hepatitis, cirrhosis and obesity, etc.); 4. Have had acupuncture or TEAS treatment; 5. Have a skin infection; 6. Communication difficulties; 7. Drug abuse/addiction; Alcoholism or addiction to alcohol; 8. Consent to another study or refuse to participate in this study.

Design outcomes

Primary

MeasureTime frame
NRS scores;

Secondary

MeasureTime frame
CPSP incidence;Intraoperative dosage of remifentanil;Postoperative supplementary analgesic drugs;Chest tube indwelling time;Incidence of postoperative nausea and vomiting;The number of indentured chest tubes 24h, 48h and 72h after surgery;Serum stress factor index: norepinephrine (NE), cortisol (Cor);Serum inflammatory response indicators: tumor necrosis factor (TNF-a)?interleukin 6 (IL-6),;

Countries

China

Contacts

Public ContactLi Na

People's Liberation Army Joint Logistic Support Force 920th Hospital

45470739@qq.com+86 18687000606

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026